Related references
Note: Only part of the references are listed.High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience
T. Gulen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM
Ivan Alvarez-Twose et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Mast cell activation syndromes: definition and classification
P. Valent
ALLERGY (2013)
Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis
Eszter Rausz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Expanding Spectrum of Mast Cell Activation Disorders: Monoclonal and Idiopathic Mast Cell Activation Syndromes
Matthieu Picard et al.
CLINICAL THERAPEUTICS (2013)
Mast Cell Activation Syndrome: A Review
Marianne Frieri et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis
Bjorn van Anrooij et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis
Ivan Alvarez-Twose et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Familial Occurrence of Systemic Mast Cell Activation Disease
Gerhard J. Molderings et al.
PLOS ONE (2013)
Severe Life-Threatening or Disabling Anaphylaxis in Patients with Systemic Mastocytosis: A Single-Center Experience
Friedrich Wimazal et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
Peter Valent et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms
I. Alvarez-Twose et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis
M. Niedoszytko et al.
ALLERGY (2011)
Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases
Gerhard J. Molderings et al.
INTERNAL MEDICINE (2011)
Tyrosine kinase inhibitors in the treatment of systemic mastocytosis
Celalettin Ustun et al.
LEUKEMIA RESEARCH (2011)
Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study
Carle Paul et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Anaphylaxis and Mast Cell Disease: What Is the Risk?
Cem Akin
CURRENT ALLERGY AND ASTHMA REPORTS (2010)
Mastocytosis and insect venom allergy
Patrizia Bonadonna et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V
Alexandra Boehm et al.
EXPERIMENTAL HEMATOLOGY (2010)
Mast cell activation syndrome: Proposed diagnostic criteria
Cem Akin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations
Christine Bodemer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives
Michel Arock et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy
M. Niedoszytko et al.
ALLERGY (2009)
Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells
M. -T. Krauth et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Assessing anaphylactic risk? Consider mast cell clonality
Dean D. Metcalfe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels
Patrizia Bonadonna et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients
K. Brockow et al.
ALLERGY (2008)
Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis
Srdan Verstovsek et al.
CLINICAL CANCER RESEARCH (2008)
Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D(2) Production
Joseph H. Butterfield et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis
David Gonzalez De Olano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Successful treatment of cutaneous mastocytosis and Meniere disease with anti-IgE therapy
Frank Siebenhaar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Novel approaches in the treatment of systemic mastocytosis
Alfonso Quintas-Cardama et al.
CANCER (2006)
KIT mutations in mastocytosis and their potential as therapeutic targets
Jason Gotlib
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2006)
Imatinib mesylate in the treatment of systemic mastocytosis - A phase II trial
Helga J. Droogendijk et al.
CANCER (2006)
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT:: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects
KV Gleixner et al.
BLOOD (2006)
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
J Gotlib et al.
BLOOD (2005)
Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis
AW van Toorenenbergen et al.
CLINICA CHIMICA ACTA (2005)
Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes
S Florian et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Diagnosis and classification of mast cell proliferative disorders: Delineation from immunologic diseases and non-mast cell hernatopoietic neoplasms
P Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Systemic mastocytosis
C Akin et al.
ANNUAL REVIEW OF MEDICINE (2004)
CD25 indicates the neoplastic phenotype of mast cells - A novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens
K Sotlar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Diagnosis and treatment of systemic mastocytosis: State of the art
P Valent et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Mastocytosis: current concepts in diagnosis and treatment
L Escribano et al.
ANNALS OF HEMATOLOGY (2002)
Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients
G Di Lorenzo et al.
ALLERGY (2002)
Serum tryptase levels in patients with mastocytosis: Correlation with mast cell burden and implication for defining the category of disease
WR Sperr et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Smouldering mastocytosis: A novel subtype of systemic mastocytosis with slow progression
P Valent et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Kit and c-kit mutations in mastocytosis:: A short overview with special reference to novel molecular and diagnostic concepts
F Féger et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Association of the Q576R polymorphism in the interleukin-4 receptor α chain with indolent mastocytosis limited to the skin
T Daley et al.
BLOOD (2001)
Diagnostic criteria and classification of mastocytosis:: a consensus proposal
P Valent et al.
LEUKEMIA RESEARCH (2001)
Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings
HP Horny et al.
LEUKEMIA RESEARCH (2001)
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis:: Evidence for expression of CD2, CD117/Kit, and bcl-xL
JH Jordan et al.
HUMAN PATHOLOGY (2001)
Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis
R Fritsche-Polanz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Variable expression of activation-linked surface antigens on human mast cells in health and disease
F Valent et al.
IMMUNOLOGICAL REVIEWS (2001)
Share Paper
